Matches in Nanopublications for { ?s ?p "[Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44%; OR 12.4, 95% confidence interval 2.4-65.1; P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- NP753016.RAfdH60R7WYpsshd-AZJ-vwIL3U0XuKgPu5ABXZJhyqw8130_assertion description "[Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44%; OR 12.4, 95% confidence interval 2.4-65.1; P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP753016.RAfdH60R7WYpsshd-AZJ-vwIL3U0XuKgPu5ABXZJhyqw8130_provenance.
- NP873778.RAhGyGunuwXExqbJeTeswtRWSxe9xJm_ayu1Day7XzTMs130_assertion description "[Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44%; OR 12.4, 95% confidence interval 2.4-65.1; P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873778.RAhGyGunuwXExqbJeTeswtRWSxe9xJm_ayu1Day7XzTMs130_provenance.
- assertion description "[Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44%; OR 12.4, 95% confidence interval 2.4-65.1; P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44%; OR 12.4, 95% confidence interval 2.4-65.1; P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP410552.RA5lVb7RP9Xq2aVcentUuuSmQfFp_4SSQSQUe_B0xdbZs130_assertion description "[Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44%; OR 12.4, 95% confidence interval 2.4-65.1; P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410552.RA5lVb7RP9Xq2aVcentUuuSmQfFp_4SSQSQUe_B0xdbZs130_provenance.
- assertion description "[Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44%; OR 12.4, 95% confidence interval 2.4-65.1; P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP648816.RAwj4whuCP-2XO5vR46VBtQTPRluWo0l5NV_IMg3-0j8Q130_assertion description "[Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44%; OR 12.4, 95% confidence interval 2.4-65.1; P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP648816.RAwj4whuCP-2XO5vR46VBtQTPRluWo0l5NV_IMg3-0j8Q130_provenance.
- NP384281.RAeDks941seqxWOA28ziZ4v8Kgk9sZs5erJ5yhj1aapSw130_assertion description "[Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44%; OR 12.4, 95% confidence interval 2.4-65.1; P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384281.RAeDks941seqxWOA28ziZ4v8Kgk9sZs5erJ5yhj1aapSw130_provenance.
- NP967824.RAZcJIt8SYVmOwGWEOIbhq7Ftc-45T7HYQq5cKFvQztZs130_assertion description "[Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44%; OR 12.4, 95% confidence interval 2.4-65.1; P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP967824.RAZcJIt8SYVmOwGWEOIbhq7Ftc-45T7HYQq5cKFvQztZs130_provenance.
- NP967823.RABJpVlKDu8m4uMkLLp24q2lZRTXU_VJe5dWpsCkg-coM130_assertion description "[Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44%; OR 12.4, 95% confidence interval 2.4-65.1; P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP967823.RABJpVlKDu8m4uMkLLp24q2lZRTXU_VJe5dWpsCkg-coM130_provenance.
- NP967825.RAjxjlqrytUSYK_8jkvaUGb__9OuHkbS5puaxw7nT_sRI130_assertion description "[Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44%; OR 12.4, 95% confidence interval 2.4-65.1; P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP967825.RAjxjlqrytUSYK_8jkvaUGb__9OuHkbS5puaxw7nT_sRI130_provenance.
- NP483212.RAjVRqc5zzFC3X8XVFJdB4xnWkJOD1hLZqe7oz4I2EzZI130_assertion description "[Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44%; OR 12.4, 95% confidence interval 2.4-65.1; P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP483212.RAjVRqc5zzFC3X8XVFJdB4xnWkJOD1hLZqe7oz4I2EzZI130_provenance.
- NP483211.RAFYPvFxveNAFLCBpqePOUe_KIklmiAPR9DsRyTVHQ1y4130_assertion description "[Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44%; OR 12.4, 95% confidence interval 2.4-65.1; P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP483211.RAFYPvFxveNAFLCBpqePOUe_KIklmiAPR9DsRyTVHQ1y4130_provenance.
- NP483213.RAIj1rjmjFZv3gR9w3ZXlTHezY8W-AHhXn7xCGu2Nx3es130_assertion description "[Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44%; OR 12.4, 95% confidence interval 2.4-65.1; P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP483213.RAIj1rjmjFZv3gR9w3ZXlTHezY8W-AHhXn7xCGu2Nx3es130_provenance.